Regencell Bioscience Holdings Ltd
RGC
$5.23
▼
-0.18
(-3.33%)
at close
9
Visible periods
5
Metrics
Peer-ranked
Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome
Analytical Summary
Regencell Bioscience Holdings Ltd faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.
Market Cap
—
Dividend Yield
—
Revenue Growth
—
Op. Margin
—
ROIC
—
FCF / Share
—
Trailing P/E
—
Price / Book
194.3x
FCF Yield
—
Debt / Equity
—
info
Valuation on last close. End-of-day price, Nov 5, 2026.
trending_up
Bullish Indicators
- No bullish signals detected.
warning
Bearish Risks
- Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile
Health Breakdown
Returns ↓
9
Cash Quality ↓
46
Financial view
Statement lens
Choose the reporting cadence, isolate a period range, or search directly for a metric.
Is the balance sheet risky?
1 metrics
| Metric | Q4 FY2026 Jun 30, 2026 20-F ↗ | Q4 FY2025 Jun 30, 2025 20-F ↗ | Q4 FY2024 Jun 30, 2024 20-F ↗ | Q4 FY2023 Jun 30, 2023 20-F ↗ | Q4 FY2022 Jun 30, 2022 20-F ↗ | Q4 FY2021 Jun 30, 2021 20-F ↗ | Q4 FY2020 Jun 30, 2020 20-F ↗ | Q4 FY2019 Jun 30, 2019 20-F ↗ | Q4 FY2018 Jun 30, 2018 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Net Debt (USD) | — | — | — | — | $-6.42M | $-59.41K | $-386.98K | $-243.31K | $-153.30K |
How resilient is the balance sheet?
2 metrics
| Metric | Q4 FY2026 Jun 30, 2026 20-F ↗ | Q4 FY2025 Jun 30, 2025 20-F ↗ | Q4 FY2024 Jun 30, 2024 20-F ↗ | Q4 FY2023 Jun 30, 2023 20-F ↗ | Q4 FY2022 Jun 30, 2022 20-F ↗ | Q4 FY2021 Jun 30, 2021 20-F ↗ | Q4 FY2020 Jun 30, 2020 20-F ↗ | Q4 FY2019 Jun 30, 2019 20-F ↗ | Q4 FY2018 Jun 30, 2018 20-F ↗ |
|---|---|---|---|---|---|---|---|---|---|
| Working Capital (USD) | $12.90M | $4.24M | $7.92M | $11.01M | $15.87M | $-4.27M | $-2.78M | — | — |
| Total Equity (USD) | $13.35M | $4.86M | $8.22M | $12.03M | $17.07M | $-4.00M | $-2.65M | $-1.84M | $-1.45M |
⌨️ Keyboard Shortcuts
/ Search
Esc Clear
A Annual
Q Quarterly
1-7 Jump to category
R Reset
Secondary lens
Benchmark Lens
Compare RGC against peers after checking the statement evidence.
Open lens
Benchmark Lens
Compare RGC against peers after checking the statement evidence.
Signals
Key bullish and bearish indicators for RGC
Bullish
0
No bullish signals detected
Bearish
1
Return on Common Equity (%)
-87.7%
Return on Common Equity (%) is in the bottom quartile
Percentile Rankings
How RGC compares to all companies
Return on Common Equity (%)
-87.7%
Bottom 25%
Peers: Top 100%
Peer Comparison
RGC vs similar peers
Return on Common Equity (%)
RGC
-87.7%
#4 of 3
TLRY
-8.0%
CXXIF
-12.8%
NAII
-41.4%
Peer median: -12.75
Profit Margin (%)
RGC
—
#None of 2
TLRY
-13.3%
NAII
-14.5%
Peer median: -13.89
Debt to Equity
RGC
—
#None of 1
TLRY
0.00x
Peer median: 0.00
Operating Margin (%)
RGC
—
#None of 2
TLRY
-6.9%
NAII
-13.2%
Peer median: -10.02
Compare RGC with peers
Stack RGC against similar companies across every metric on this page.
north_east Open comparisonbar_chart Data from SEC EDGAR XBRL filings
Synced 4 days ago 9 years · 9 quarters